TGFB1 and cancer: Neutralizing antibodies against five arbitrarily selected pleiotropic proteins present in MAs (TGF-β1, HGF, EGF, IGF-1, GRO-1 [8,15]) were used to check whether inhibition of these agents translates to decreased adhesion of cancer cells to PMCs or PFBs.